Kirk's Market Thoughts Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Kirk's Market Thoughts

COHR 190.88

+2.8%

Dec 22 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: rdkflorida2 who wrote (12778)	1/24/2022 12:00:54 PM
From: Kirk ©	Read Replies (1) of 26822

If you look at success as "not dying" then I'd say the "Trump vaccines" are a success but Biden won't say that so many of Trump's followers won't take the shots despite Trump himself taking the jabs. Crazy world... It would be interesting to see how many who don't get the Trump Vaccines also don't get flu shots. Maybe they are the same and would rather face being very sick for a few weeks and possibly dying rather than some side effects that are not nearly as deadly. I was in that camp with flu shot until I got old enough the flu poses higher risk... Then my insurance company thought enough of the protection to pay for it so it was even easier. reuters.com January 24, 2022 1:12 AM PST Fourth COVID vaccine shot raises resistance to serious illness for over-60s: Israel Reuters JERUSALEM, Jan 23 (Reuters) - A fourth dose of COVID-19 vaccine given to people over 60 in Israel made them three times more resistant to serious illness than thrice-vaccinated people in the same age group, Israel's Health Ministry said on Sunday. The ministry also said the fourth dose, or second booster, made people over 60 twice as resistant to infection than those in the age group who received three shots of the vaccine. A preliminary study published by Israel's Sheba medical centre last Monday found that the fourth shot increases antibodies to even higher levels than the third but "probably" not to the point that it could completely fend off the highly transmissible Omicron variant. Israel began offering a fourth dose of the Pfizer/BioNtech vaccine to people over 60 earlier this month as Omicron swept the country. The ministry said on Sunday the study it conducted with several major Israeli universities and the Sheba centre compared 400,000 people over 60 who received the second booster with 600,000 people in the age group who were given a third shot more than four months ago. As elsewhere, Israel has seen COVID-19 cases spiral due to Omicron. But it has logged no deaths from the variant. Reporting by Jeffrey Heller; Editing by Andrew Cawthorne and Frances Kerry

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next